Cryoablation: A Promising Treatment for Early-Stage Breast Cancer in Older Women
Breaking News: A New Hope for Breast Cancer Patients
In a groundbreaking presentation at RSNA 2025, researchers unveiled an innovative approach to treating early-stage breast cancer in older women. Ultrasound-guided cryoablation has emerged as a safe and effective alternative, offering new possibilities for this vulnerable patient group.
But here's where it gets controversial...
Dr. Jorge Rey Porras and his team from La Paz University Hospital in Madrid, Spain, presented compelling evidence supporting cryoablation's efficacy in treating estrogen receptor (ER) positive and negative cancers at clinical stages I and II. Porras emphasized that cryoablation is a minimally invasive procedure, making it an attractive option for elderly women with ER+ cancer, who often face comorbidities that prevent surgical treatment.
The Debate: Surgery vs. Cryoablation
Traditionally, sentinel lymph node biopsy has been a part of the treatment protocol. However, recent studies suggest that omitting this step in ER+ cases does not increase disease recurrence. This finding is a game-changer, as it could help older women avoid surgical complications.
Exploring Cryoablation's Potential
Researchers are actively investigating cryoablation's role in treating small tumors with minimal invasiveness. Previous research has highlighted its effectiveness, safety, and patient tolerance. Porras and his colleagues conducted a retrospective review of 77 women with a total of 82 early-stage invasive breast tumors, with a minimum follow-up of 18 months. The women's ages ranged from 58 to 96, with an average age of 83.
The results were remarkable. Ultrasound-guided cryoablation achieved a 100% overall local control rate in ER+ cases and an impressive 84.6% in ER- cases. The ER+ group experienced a longer average time to recurrence (21 months) and follow-up duration (31 months) compared to the ER- group (10 months and 20 months, respectively).
A Safe and Effective Alternative
Porras's team reported no major complications in either group, further emphasizing cryoablation's safety profile. The findings strongly suggest that cryoablation is a viable alternative for elderly women with early-stage, ER+ breast cancer. This treatment approach could potentially eliminate the need for axillary surgery without compromising local control.
The Future of Cryoablation
Porras expressed interest in exploring cryoablation's role in younger patients with combined therapies. This opens up exciting possibilities for further research and treatment advancements.
The research received well-deserved recognition with a Trainee Research Prize from RSNA. To delve deeper into the full coverage of RSNA 2025, visit our RADCast (https://www.auntminnie.com/resources/conference/rsna/2025?page=1).
And this is the part most people miss...
While cryoablation shows promise, it's essential to consider individual patient needs and carefully select candidates for this treatment. As with any medical advancement, further research and clinical trials will shape the future of cryoablation in breast cancer treatment.
What are your thoughts on cryoablation as a treatment option? Do you think it could revolutionize breast cancer care for older women? Share your insights and join the discussion in the comments below!
